KLOW Blend is a four-compound research-supply formulation extending the three-compound Glow Blend with an additional dose of the α-MSH C-terminal tripeptide KPV. Per-component loadings are listed in the Definition section below. KPV adds a fourth non-overlapping mechanism niche — intestinal-epithelial-cell anti-inflammatory signalling via PepT1 — to the angiogenic and skin-regeneration arms covered by the other three components.
Definition
KLOW Blend is an 80 mg combined-formulation lyophilised vial containing four research peptides at fixed per-vial loadings: 50 mg of GHK-Cu (the dominant component by mass) plus three 10 mg components — BPC-157, TB-500, and KPV. The formulation extends the three-compound Glow Blend composition with the addition of the KPV tripeptide — the C-terminal Lys-Pro-Val fragment of α-melanocyte-stimulating hormone with documented anti-inflammatory activity in intestinal-epithelial-cell research contexts.
The lyophilised powder carries a blue tint from the Cu(II) chromophore of the GHK-Cu component, identical to the Glow Blend appearance. The BPC-157, TB-500, and KPV components do not contribute to the colour.
How the combination is used in research workflows
The mechanistic rationale extends the three-compound Glow Blend framing with an additional inflammation-pathway arm. GHK-Cu engages copper-dependent fibroblast and keratinocyte signalling. BPC-157 engages the VEGFR2-Akt-eNOS angiogenic cascade. TB-500 engages G-actin sequestration and integrin-linked kinase signalling. KPV engages PepT1-mediated intestinal-epithelial uptake with downstream NF-κB-pathway modulation. The four pathways do not compete at the receptor or signalling-pathway level.
A standard 80 mg vial reconstituted with 2 mL of bacteriostatic water yields GHK-Cu at 25 mg/mL, BPC-157 at 5 mg/mL, TB-500 at 5 mg/mL, and KPV at 5 mg/mL simultaneously. Researchers studying combined-mechanism protocols across angiogenesis, tissue-repair, and inflammation contexts use the four-compound format to engage all four mechanism niches from a single reconstituted stock. Researchers who prefer to control component concentrations independently can use the standalone single-compound vials for each.
Related terms
- Glow Blend (three-compound subset)
- GHK-Cu
- BPC-157
- TB-500
- KPV
Where KLOW Blend appears in the Ronin catalog
- KLOW Blend 80mg — four-compound combined-formulation vial
- Glow Blend 70mg — three-compound subset (no KPV)
- Single-component standalone vials: GHK-Cu, BPC-157, TB-500, KPV
References
- See the individual component entries for the underlying primary research: GHK-Cu, BPC-157, TB-500, KPV.
Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. KLOW Blend is sold strictly as a research-grade reagent for laboratory and bench research applications.